Brief: Kuros FY revenue up at CHF 1.06 million

Kuros Biosciences AG

26/04/2017 06:13

April 26 (Reuters) - Kuros Biosciences AG  KURN.S : 
    * Merger successfully completed: Cytos Biotechnology and 
Kuros Biosurgery Holding combined their businesses to create 
Kuros Biosciences, a future leader in tissue repair and 
regeneration 
    * FY net loss of CHF 19.7 million ($19.86 million) versus 
loss CHF 5.8 million year ago 
    * Expects to receive CE mark certification for neuroseal in 
next months 
    * FY revenue of CHF 1.06 million versus CHF 144,000 year ago 
 
     
     
Source text for Eikon:  ID:nTEN32dn8a  
Further company coverage:  KURN.S  
 
($1 = 0.9921 Swiss francs) 
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))